fda glp-1 compounding crackdown news The is proposing the removal of three drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday May 18, 2026: FDA warns

No compounded oral tablets, drops, or microdose formats are available, and Ozempic and Mounjaro are not on the menu

living with diabetes, and about 90% of cases being Type 2 diabetes, awareness and early detection are crucial

However, the long half-life also means that Prozac can take more time to discontinue or switch away from compared to Lexapro

TB-500 research in full-thickness wound models reports re-epithelialization rates increased by 42% at day 4 and 61% at day 7 compared to saline controls

Malkowski notes observations of individuals on GLP1 medications demonstrating gut microbiome dysbiosis, reduced diversity, reduced phyla abundance, and key bacteria